glucuronic acid has been researched along with p-methoxy-n-methylphenethylamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, SH; Jeong, HJ; Kim, HM; Lee, SA; Moon, PD; Na, HJ; Park, RK; Um, JY | 1 |
| Bento, D; Borges, O; Gonçalves, T; Staats, HF | 1 |
2 other study(ies) available for glucuronic acid and p-methoxy-n-methylphenethylamine
| Article | Year |
|---|---|
Alginic acid has anti-anaphylactic effects and inhibits inflammatory cytokine expression via suppression of nuclear factor-kappaB activation.
Topics: Alginates; Animals; Anti-Allergic Agents; Blotting, Western; Calcimycin; Cell Line; Cytokines; Glucuronic Acid; Hexuronic Acids; Histamine Release; Histidine Decarboxylase; Ionophores; Male; Mast Cells; Models, Animal; NF-kappa B; p-Methoxy-N-methylphenethylamine; Passive Cutaneous Anaphylaxis; Peritoneum; Rats; Rats, Wistar; Skin Tests; Tetradecanoylphorbol Acetate | 2006 |
Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.
Topics: Adjuvants, Immunologic; Administration, Intranasal; Alginates; Animals; Anthrax; Anthrax Vaccines; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Toxins; Biomarkers; Chemistry, Pharmaceutical; Chitosan; Dose-Response Relationship, Drug; Drug Carriers; Female; Glucuronic Acid; Hexuronic Acids; Humans; Immunity, Mucosal; Immunization; Mast Cells; Mice; Mice, Inbred C57BL; Nanomedicine; Nanoparticles; Nasal Mucosa; p-Methoxy-N-methylphenethylamine; Particle Size; RAW 264.7 Cells; Surface Properties; T-Lymphocytes, Helper-Inducer; Technology, Pharmaceutical; Time Factors | 2015 |